Drugs / NouvSoma001
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT06620809 | Mar 2025 → Nov 2026 expected | neuromyelitis optica | Tongji Hospital | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NouvSoma001 | “human-induced neural stem cell-derived extracellular vesicles (NouvSoma001)” NCT06620809 ↗ |